“Isomorphic Labs expects to have its first clinical trials by the end of 2026.”
Founder and CEO, Isomorphic Labs; CEO, Google DeepMind; 2024 Nobel laureate in Chemistry
Said Jan 20, 2026Deadline Dec 31, 2026Reuters, 'Google-backed Isomorphic Labs delays clinical trial timeline', World Economic Forum, Davos, 20 January 2026
This is the revised version of Hassabis's missed end-2025 target; as of September 2026 no Isomorphic Labs trial start has been announced, and the deadline runs to 31 December 2026.